Zhende Medical Co., Ltd.
603301
Rank in Stocks
#4845
Zhende Medical Co., Ltd. engages in the research and development, production,... Zhende Medical Co., Ltd. engages in the research and development, production, and sale of medical care and protective equipment in China and internationally. The company offers gauze swab, lap sponge, and fluff gauze swab; non-woven swab; PBT bandage, elastic bandage, crepe bandage, crochet bandage, selvedge bandage, under-cast padding, and fluff gauze roll; dressing set; first aid kit; cotton pad and applicator; and gauze roll and abdominal pad. It also provides surgical gown, scrub suit, warm-up jacket, surgical headwear, and isolation gown; Surgical drape; standard surgical pack and custom procedure pack; equipment cover; OP Tape, hand towel, and fluid collection pouch; latex surgical glove; CSR wrap; and warming blanket system. In addition, the company offers isolation gown, surgical cap, shoe cover, medical mask, and particular respirator; compression bandage and compression stocking; wound care products; pre-filled flush syringes; and ostomy and accessories. Further, it provides respiratory health, home cleaning, IP collaboration, nasal care, protective gear and assistive devices, and personal beauty products. Zhende Medical Co., Ltd. was incorporated in 1994 and is headquartered in Shaoxing, China.
Share Price
$11.60
Last synced: 2026-10-20
Market Cap
$3.06B
Change (1 day)
2.99%
Change (1 year)
16.47%
Country
CN
Trade Zhende Medical Co., Ltd. (603301)
Category
Healthcare
Revenue for Zhende Medical Co., Ltd. (603301)
Revenue in Jun 2026 TTM: $645.37M
According to Zhende Medical Co., Ltd. latest financial reports the company's current revenue (TTM) is $645.37M. In 2023 the company made a revenue of $583.03M a decrease compared to the revenue in the year 2022 that was $889.78M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Zhende Medical Co., Ltd. from 2014 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $645.37M | 10.48% |
| 2024 | $584.17M | 0.19% |
| 2023 | $583.03M | -34.47% |
| 2022 | $889.78M | 11.07% |
| 2021 | $801.08M | -49.67% |
| 2020 | $1.59B | 493.45% |
| 2019 | $268.22M | 29.12% |
| 2018 | $207.72M | 3.45% |
| 2017 | $200.80M | 34.71% |
| 2016 | $149.06M | -5.20% |
| 2015 | $157.23M | -1.32% |
| 2014 | $159.33M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $11.03B | 1,609.78% |
US
|
|
| $34.74B | 5,282.43% |
FR
|
|
| - | - |
JP
|
|
| $20.84B | 3,129.01% |
US
|
|
| - | - |
CH
|
